In malignant melanoma, some studies demonstrated reduced STAT 1 activity in IFN-resistant cell lines pointing to defects in the JAK/STAT pathways (Wong et al, 1997; Pansky et al, 2000). The gene discussed is IFNA1; the disease is melanoma.